Digital health company Adherium has listed on the Australian Securities Exchange for the first time, opening yesterday at $0.55 per share. [ + ]

Experts in health ethics, policy, patient care and innovation are among those who have been appointed to the National Health and Medical Research Council's five committees. [ + ]

CSIRO is leading an international collaboration of researchers, beekeepers, farmers, industry and technology companies that aims to better understand what is harming the health and pollination ability of honey bees.

Law firm DibbsBarker has announced the appointment of Andrew Rankine as a new special counsel in the company's Sydney office. [ + ]

Terem Technologies has conducted what it claims is the first study into the growth of female technology entrepreneurs, with surprising results. [ + ]

Thanks to a computer program developed at Edith Cowan University, plant classification could become as simple as taking a photo. [ + ]

Specialised Therapeutics Australia has formed an exclusive licence and commercialisation agreement with PharmaMar to market and distribute the oncology drug APLIDIN (plitidepsin) in Australia and New Zealand. [ + ]

Clarity Pharmaceuticals and the University of Melbourne have been awarded an ARC Linkage grant to fund the development of new agents for diagnostic imaging using PET. The ultimate aim of the project is to try to improve molecular imaging of the brain for various disorders. [ + ]

Three Australian research teams will contribute to a global effort to combat the growing incidence of type 2 diabetes, having received NHMRC funding as part of a multicountry grant call through the Global Alliance for Chronic Diseases. [ + ]

Professor Allan Pacey has released an inside look at the process of conception in the human body, framing it as an amazing race between 250 million competitors. [ + ]

Drug developer Paradigm Biopharmaceuticals has listed on the Australian Securities Exchange for the first time. [ + ]

The Westmead Millennium Institute for Medical Research will next month host the 11th annual Indo-Australian Biotechnology Conference, providing an opportunity for Australian medical researchers to forge closer links with their Indian counterparts. [ + ]

The increasing amount of money spent on biomedical research in the US over the past 50 years has resulted in diminished return on investment in terms of life-expectancy gains and new drug approvals, according to researchers from the Johns Hopkins Bloomberg School of Public Health. [ + ]

Prima BioMed will receive a clinical milestone payment from Novartis relating to the latter's IMP701 LAG-3 antibody, which is being trialled for the treatment of cancer. [ + ]

Australian and German scientists have collaborated on the demonstration of a diamond laser that is said to be 20 times more powerful than previous diamond lasers. [ + ]